KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1384 |
|---|---|
| Product Name | Anti-Human CD192 Recombinant Antibody |
| Molecular Name | Plozalizumab |
| Alias | Anti-CD192 Recombinant Antibody, Research Grade Plozalizumab |
| CAS Number | 1610761-46-0 |
| Target | CD192[Homo sapiens] |
| Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | ELISA, IHC, IF, IP, FCM, Inhib |
| Buffer | PBS, pH7.5 |
| Background | Plozalizumab (INN, hu1D9) is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency. This drug was developed by Takeda Pharmaceuticals International Co. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
